REFERENCES
- Diabetes mellitus in thalasseamia- TIF guidelines, 2008.
- Au WY, Lam WW, Chu W, et al. A T2* magnetic resonance imaging study of pancreatic iron overload in thalassemia major. Haematologica. 2008;93:116–119.
- Lassman MN, Genel M, Wise JK, et al. Carbohydrate homeostasis and pancreatic islet cell function in thalassemia. Ann Intern Med. 1974;80:65–69.
- Bunn HF, Forget BG, Ranney HM. Hemoglobinopathies (review). Major Probl Intern Med. 1977;12:1–291.
- Costin G, Kogut MD, Hyman C, et al. Carbohydrate metabolism and pancreatic islet-cell function in thalassemia major. Diabetes. 1977;26:230–240.
- Mowla A, Karimi M, Afrasiabi A, et al. Prevalence of diabetes mellitus and impaired glucose tolerance in beta-thalassemia patients with and without hepatitis C virus infection. Pediatr Endocrinol Rev. 2004;2(Suppl. 2):282–284.
- British National Formulatory, 58th ed. London: BMJ Group and RPS Publishing. 2000. www.bnf.org
- Messina MF, Lombardo F, Meo A, et al. Three-year prospective evaluation of glucose tolerance, beta-cell function and peripheral insulin sensitivity in non-diabetic patients with thalassemia major. J Endocrinol Invest. 2002;25:497–501.
- Platis O, Anagnostopoulos G, Farmaki K, et al. Glucose metabolism disorders improvement in patients with thalassaemia major after 24–36 months of intensive chelation therapy. Pediatr Endocrinol Rev. 2004;2(Suppl. 2):279–281.
- Christoforidis A, Perifanis V, Athanassiou-Metaxa M. Combined chelation therapy improves glucose metabolism in patients with beta-thalassaemia major. Br J Haematol. 2006;135(2):271–272.